Steven Siegel, MD, PhD

Title(s)Professor and Chair, Psychiatry and the Behavioral Sciences
SchoolKeck School of Medicine of Usc
AddressCSC 2250 Alcazar St.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard
    Other Positions
    Title(s)Franz Alexander Chair in Psychiatry

    Collapse Overview 
    Collapse Overview
    Dr. Steven Siegel was appointed Professor and Chair of the Department of Psychiatry and the Behavioral Sciences at the Keck School of Medicine of USC in July 2016. He is a physician-scientist specializing in the treatment of psychosis.

    Dr. Siegel came to USC after 20 years at the University of Pennsylvania, where he had roles in research, teaching and clinical care. He received his B.A. in Neuroscience at Colgate University in 1986, and his M.D. and Ph.D. in Neurobiology at the Mount Sinai School of Medicine in 1996. He later completed a MacArthur Foundation Training Fellowship before completing his residency in Psychiatry and a Fellowship in Neuropsychiatry at the University of Pennsylvania.

    Prior to joining USC, Dr. Siegel was involved in, medical, undergraduate and graduate education. He was Associate Director of Masters in Translational Research for 6 years at the University of Pennsylvania. He directed a course on Therapeutics and Commercialization at Penn, based on his experience with technology transfer. Other major educational roles at Penn included Director of the Clinical Training Program that spanned 6 clinical specialties. He was named one of the nation’s outstanding clinicians by the National Association for Mental Illness.

    Dr. Siegel has made contributions to understanding the neurobiology of schizophrenia, autism, and drug dependence. His laboratory uses animal models to evaluate EEG, combined with behavioral and molecular studies. Additionally, he invented, patented, and licensed a new method of treatment for schizophrenia using biodegradable implants, which successfully completed a pivotal Phase 3 clinical trial and has been submitted as an NDA to the FDA for consideration.

    In his current role as Chair of the Department of Psychiatry and the Behavioral Sciences, Dr. Siegel oversees operations for a department comprised of 200 faculty members, 50 staff members and 100 residents, fellows, and trainees; more than tripling the size of the department in 5 years since he arrived. His department provides a broad range of mental health services to children and adults at LAC+USC Medical Center including Emergency, Inpatient, and Outpatient Services. Additionally, he has expanded and improved the quality of mental health services at Keck Medicine and USC Care, with an emphasis on consultation liaison and specialty services. During his first year at USC he designed and oversaw the incorporation of student mental health services into Keck Medicine of USC. He continues to lead and guide the evolution of student mental health services at USC, both within Student Health, and in the new Keck Medicine student outpatient practice that launched in late 2019. He was named the inaugural Chief Mental Health and Wellness Officer for Keck Medicine of USC in 2021, with responsibility and oversight of mental health services across the Keck enterprise as well as leadership of wellness program as part of Keck Medicine’s nationally acclaimed Care for the Caregiver program.

    Over his career at Penn and USC, Dr. Siegel has mentored more than 150 graduate and undergraduate trainees in neuroscience and bioengineering. His research has been supported by federal, state, foundation, and industry sources for more than 25 years. He has published approximately 150 manuscripts as well as multiple book chapters, and one book spanning topics related to drug abuse, basic research in schizophrenia and autism, as well as clinical aspects of schizophrenia.
    Collapse Websites

    Collapse Research 
    Collapse Research Activities and Funding
    Mentored Career Development
    NIH KL2TR001854Jul 1, 2016 - May 31, 2021
    Role: Principal Investigator
    Long-term neurobehavioral effects of ketamine exposure in adolescent mice
    NIH R01DA023210Feb 1, 2008 - Jan 31, 2014
    Role: Principal Investigator
    Src hypoactivity as a mediator of various molecular alterations leading to NMDAR
    NIH R01MH075916Dec 1, 2005 - Jan 31, 2021
    Role: Co-Principal Investigator
    An Implantable Semiannual Antipsychotic Delivery System
    NIH R01MH074672Jul 1, 2005 - Nov 30, 2015
    Role: Principal Investigator
    Evoked potentials and vulnerability to ketamine in mice.
    NIH R21DA017082Sep 30, 2003 - Jul 31, 2005
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Calcium/calmodulin-dependent protein kinase IIα heterozygous knockout mice show electroencephalogram and behavioral changes characteristic of a subpopulation of schizophrenia and intellectual impairment. Neuroscience. 2022 09 01; 499:104-117. Featherstone RE, Shimada T, Crown LM, Melnychenko O, Yi J, Matsumoto M, Tajinda K, Mihara T, Adachi M, Siegel SJ. PMID: 35901933.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Frequency-specific medial septal nucleus deep brain stimulation improves spatial memory in MK-801-treated male rats. Neurobiol Dis. 2022 08; 170:105756. Zepeda NC, Crown LM, Medvidovic S, Choi W, Sheth M, Bergosh M, Gifford R, Folz C, Lam P, Lu G, Featherstone R, Liu CY, Siegel SJ, Lee DJ. PMID: 35584727; PMCID: PMC9343054.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    3. Early life social instability stress causes lasting cognitive decrement and elevated hippocampal stress-related gene expression. Exp Neurol. 2022 08; 354:114099. Featherstone RE, Gifford RL, Crown LM, Amirfathi F, Alaniz JP, Yi J, Tran A, Adomian D, Schwenk A, Melnychenko O, Duval C, Parekh K, Lee DJ, Siegel SJ. PMID: 35490720.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    4. Aberrant functional connectivity between reward and inhibitory control networks in pre-adolescent binge eating disorder. Psychol Med. 2023 07; 53(9):3869-3878. Murray SB, Alba C, Duval CJ, Nagata JM, Cabeen RP, Lee DJ, Toga AW, Siegel SJ, Jann K. PMID: 35301976.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    5. Regional gray matter abnormalities in pre-adolescent binge eating disorder: A voxel-based morphometry study. Psychiatry Res. 2022 04; 310:114473. Murray SB, Duval CJ, Balkchyan AA, Cabeen RP, Nagata JM, Toga AW, Siegel SJ, Jann K. PMID: 35220054.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. High-beta/low-gamma frequency activity reflects top-down predictive coding during a spatial working memory test. Exp Brain Res. 2019 Jul; 237(7):1881-1888. Zhang RV, Featherstone RE, Melynchenko O, Gifford R, Weger R, Liang Y, Siegel SJ. PMID: 31093716.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    7. Parvalbumin Cell Ablation of NMDA-R1 Leads to Altered Phase, But Not Amplitude, of Gamma-Band Cross-Frequency Coupling. Brain Connect. 2019 04; 9(3):263-272. Port RG, Berman JI, Liu S, Featherstone RE, Roberts TPL, Siegel SJ. PMID: 30588822; PMCID: PMC6479236.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    8. Src deficient mice demonstrate behavioral and electrophysiological alterations relevant to psychiatric and developmental disease. Prog Neuropsychopharmacol Biol Psychiatry. 2019 07 13; 93:84-92. Ward KR, Featherstone RE, Naschek MJ, Melnychenko O, Banerjee A, Yi J, Gifford RL, Borgmann-Winter KE, Salter MW, Hahn CG, Siegel SJ. PMID: 30826459.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    9. Pyramidal cell-selective GluN1 knockout causes impairments in salience attribution and related EEG activity. Exp Brain Res. 2018 03; 236(3):837-846. Forrest AD, Bang J, Featherstone RE, Bloom JH, Luminais MS, Zhang RV, Gajewski CR, McMullen MF, Liang Y, Siegel SJ. PMID: 29350251.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    10. Protocadherin 10 alters γ oscillations, amino acid levels, and their coupling; baclofen partially restores these oscillatory deficits. Neurobiol Dis. 2017 Dec; 108:324-338. Port RG, Gajewski C, Krizman E, Dow HC, Hirano S, Brodkin ES, Carlson GC, Robinson MB, Roberts TPL, Siegel SJ. PMID: 28844789.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    11. Mismatch negativity in preclinical models of schizophrenia. Schizophr Res. 2018 01; 191:35-42. Featherstone RE, Melnychenko O, Siegel SJ. PMID: 28768598.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    12. Amygdala activity associated with social choice in mice. Behav Brain Res. 2017 08 14; 332:84-89. Mihara T, Mensah-Brown K, Sobota R, Lin R, Featherstone R, Siegel SJ. PMID: 28438555.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    13. Metabotropic Glutamate Receptor 5 as a Point of Convergence for Models of Obsessive-Compulsive Disorder and Autism Spectrum Disorder. Biol Psychiatry. 2016 10 01; 80(7):504-6. Matosin N, Siegel SJ. PMID: 27601339.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models. Front Behav Neurosci. 2016; 10:136. Choi CH, Schoenfeld BP, Bell AJ, Hinchey J, Rosenfelt C, Gertner MJ, Campbell SR, Emerson D, Hinchey P, Kollaros M, Ferrick NJ, Chambers DB, Langer S, Sust S, Malik A, Terlizzi AM, Liebelt DA, Ferreiro D, Sharma A, Koenigsberg E, Choi RJ, Louneva N, Arnold SE, Featherstone RE, Siegel SJ, Zukin RS, McDonald TV, Bolduc FV, Jongens TA, McBride SM. PMID: 27445731; PMCID: PMC4928101.
      View in: PubMed   Mentions: 24  
    15. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder. J Neurosci. 2015 Dec 09; 35(49):16282-94. Kogan JH, Gross AK, Featherstone RE, Shin R, Chen Q, Heusner CL, Adachi M, Lin A, Walton NM, Miyoshi S, Miyake S, Tajinda K, Ito H, Siegel SJ, Matsumoto M. PMID: 26658876; PMCID: PMC6605504.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    16. The Role of Nicotine in Schizophrenia. Int Rev Neurobiol. 2015; 124:23-78. Featherstone RE, Siegel SJ. PMID: 26472525.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    17. Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behav Neurosci. 2015 Aug; 129(4):389-98. Sobota R, Mihara T, Forrest A, Featherstone RE, Siegel SJ. PMID: 26214213; PMCID: PMC4518468.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    18. EEG biomarkers of target engagement, therapeutic effect, and disease process. Ann N Y Acad Sci. 2015 May; 1344:12-26. Featherstone RE, McMullen MF, Ward KR, Bang J, Xiao J, Siegel SJ. PMID: 25823856.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    19. [Ketamine alters socially-evoked activity in the amygdala]. Nihon Yakurigaku Zasshi. 2014 Dec; 144(6):272-6. Mihara T, Siegel SJ. PMID: 25492362.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    20. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population. Neurobiol Dis. 2015 Jan; 73:289-95. Featherstone RE, Shin R, Kogan JH, Liang Y, Matsumoto M, Siegel SJ. PMID: 25461194.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    21. Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biol Psychiatry. 2015 Mar 15; 77(6):556-68. Tatard-Leitman VM, Jutzeler CR, Suh J, Saunders JA, Billingslea EN, Morita S, White R, Featherstone RE, Ray R, Ortinski PI, Banerjee A, Gandal MJ, Lin R, Alexandrescu A, Liang Y, Gur RE, Borgmann-Winter KE, Carlson GC, Hahn CG, Siegel SJ. PMID: 25156700; PMCID: PMC4297754.
      View in: PubMed   Mentions: 56     Fields:    Translation:AnimalsCells
    22. Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits. Neuropsychopharmacology. 2014 Jun; 39(7):1603-13. Billingslea EN, Tatard-Leitman VM, Anguiano J, Jutzeler CR, Suh J, Saunders JA, Morita S, Featherstone RE, Ortinski PI, Gandal MJ, Lin R, Liang Y, Gur RE, Carlson GC, Hahn CG, Siegel SJ. PMID: 24525709; PMCID: PMC4023157.
      View in: PubMed   Mentions: 58     Fields:    Translation:AnimalsCells
    23. Electroencephalographic and early communicative abnormalities in Brattleboro rats. Physiol Rep. 2013 Oct; 1(5):e00100. Lin RE, Ambler L, Billingslea EN, Suh J, Batheja S, Tatard-Leitman V, Featherstone RE, Siegel SJ. PMID: 24303172; PMCID: PMC3841036.
      View in: PubMed   Mentions: 3     Fields:    
    24. Capacity, confidentiality and consequences: balancing responsible medical care with mental health law. Curr Psychiatry Rep. 2013 Aug; 15(8):380. Siegel SJ. PMID: 23881711; PMCID: PMC3786359.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Animal models and measures of perceptual processing in schizophrenia. Neurosci Biobehav Rev. 2013 Nov; 37(9 Pt B):2092-8. Siegel SJ, Talpos JC, Geyer MA. PMID: 23867801; PMCID: PMC3849201.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    26. Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes. Autism Res. 2013 Apr; 6(2):69-77. Saunders JA, Tatard-Leitman VM, Suh J, Billingslea EN, Roberts TP, Siegel SJ. PMID: 23441094; PMCID: PMC4064157.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCells
    27. Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression. Psychopharmacology (Berl). 2013 Jun; 227(4):639-49. Featherstone RE, M Tatard-Leitman V, Suh JD, Lin R, Lucki I, Siegel SJ. PMID: 23392353; PMCID: PMC3808977.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    28. The electrophysiological signature of motivational salience in mice and implications for schizophrenia. Neuropsychopharmacology. 2012 Dec; 37(13):2846-54. Moessnang C, Habel U, Schneider F, Siegel SJ. PMID: 22910459; PMCID: PMC3499726.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    29. Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials. PLoS One. 2012; 7(7):e39775. Featherstone RE, Phillips JM, Thieu T, Ehrlichman RS, Halene TB, Leiser SC, Christian E, Johnson E, Lerman C, Siegel SJ. PMID: 22911690; PMCID: PMC3401200.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    30. Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice. Neurobiol Dis. 2012 Sep; 47(3):338-46. Featherstone RE, Liang Y, Saunders JA, Tatard-Leitman VM, Ehrlichman RS, Siegel SJ. PMID: 22627142.
      View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
    31. Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. Behav Neurosci. 2012 Apr; 126(2):332-43. Cao YA, Featherstone RE, Gandal MJ, Liang Y, Jutzeler C, Saunders J, Tatard-Leitman V, Chen J, Weinberger DR, Lerman C, Siegel SJ. PMID: 22309446.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    32. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. Neurobiol Dis. 2012 Apr; 46(1):88-92. Liao W, Gandal MJ, Ehrlichman RS, Siegel SJ, Carlson GC. PMID: 22249109; PMCID: PMC3299908.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    33. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One. 2011; 6(10):e26077. Mehta MV, Gandal MJ, Siegel SJ. PMID: 22016815; PMCID: PMC3189241.
      View in: PubMed   Mentions: 73     Fields:    Translation:Animals
    34. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia. Proc Natl Acad Sci U S A. 2011 Oct 25; 108(43):E962-70. Carlson GC, Talbot K, Halene TB, Gandal MJ, Kazi HA, Schlosser L, Phung QH, Gur RE, Arnold SE, Siegel SJ. PMID: 21969553; PMCID: PMC3203764.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    35. Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology. 2012 Mar; 62(3):1504-18. Gandal MJ, Edgar JC, Klook K, Siegel SJ. PMID: 21349276; PMCID: PMC3264822.
      View in: PubMed   Mentions: 138     Fields:    Translation:HumansAnimals
    36. Validating γ oscillations and delayed auditory responses as translational biomarkers of autism. Biol Psychiatry. 2010 Dec 15; 68(12):1100-6. Gandal MJ, Edgar JC, Ehrlichman RS, Mehta M, Roberts TP, Siegel SJ. PMID: 21130222; PMCID: PMC5070466.
      View in: PubMed   Mentions: 156     Fields:    Translation:HumansAnimals
    37. Ketamine modulates theta and gamma oscillations. J Cogn Neurosci. 2010 Jul; 22(7):1452-64. Lazarewicz MT, Ehrlichman RS, Maxwell CR, Gandal MJ, Finkel LH, Siegel SJ. PMID: 19583475.
      View in: PubMed   Mentions: 109     Fields:    Translation:Animals
    38. Mouse behavioral endophenotypes for schizophrenia. Brain Res Bull. 2010 Sep 30; 83(3-4):147-61. Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, McCarren HS, Siegel SJ. PMID: 20433908.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimals
    39. Psychiatric health care provider attitudes towards implantable medication. Psychiatry Res. 2010 May 15; 177(1-2):167-71. Dankert ME, Brensinger CM, Ralph LN, Seward DA, Bilker WB, Siegel SJ. PMID: 20378184.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Predator odor modulates auditory event-related potentials in mice. Neuroreport. 2009 Sep 23; 20(14):1260-4. Halene TB, Talmud J, Jonak GJ, Schneider F, Siegel SJ. PMID: 19625986.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    41. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res. 2009 Oct 19; 1294:116-27. Ehrlichman RS, Luminais SN, White SL, Rudnick ND, Ma N, Dow HC, Kreibich AS, Abel T, Brodkin ES, Hahn CG, Siegel SJ. PMID: 19643092; PMCID: PMC2771287.
      View in: PubMed   Mentions: 55     Fields:    Translation:Animals
    42. Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice. J Pharmacol Exp Ther. 2009 Oct; 331(1):308-18. Bodarky CL, Halene TB, Ehrlichman RS, Banerjee A, Ray R, Hahn CG, Jonak G, Siegel SJ. PMID: 19602553; PMCID: PMC2766227.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    43. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials. Neurobiol Dis. 2009 Aug; 35(2):311-7. Amann LC, Halene TB, Ehrlichman RS, Luminais SN, Ma N, Abel T, Siegel SJ. PMID: 19467327; PMCID: PMC2726963.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    44. Profile of auditory information-processing deficits in schizophrenia. Psychiatry Res. 2009 Jan 30; 165(1-2):27-37. Turetsky BI, Bilker WB, Siegel SJ, Kohler CG, Gur RE. PMID: 18990453; PMCID: PMC2652872.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    45. Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials. Psychopharmacology (Berl). 2009 Mar; 202(4):745-51. Rudnick ND, Koehler C, Picciotto MR, Siegel SJ. PMID: 18931833.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    46. Male and female mice differ for baseline and nicotine-induced event related potentials. Behav Neurosci. 2008 Oct; 122(5):982-90. Amann LC, Phillips JM, Halene TB, Siegel SJ. PMID: 18823155.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    47. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice. J Cogn Neurosci. 2008 Aug; 20(8):1403-14. Ehrlichman RS, Maxwell CR, Majumdar S, Siegel SJ. PMID: 18303985.
      View in: PubMed   Mentions: 72     Fields:    Translation:Animals
    48. Attitudes of patients and family members towards implantable psychiatric medication. Schizophr Res. 2008 Oct; 105(1-3):279-86. Dankert ME, Brensinger CM, Metzger KL, Li C, Koleva SG, Mesén A, Laprade B, Wiguna T, Han C, Farooq S, Severus WE, Gayares JG, Langosch JM, Lallart X, Tateno M, Mihai A, Nair SR, Belmaker R, Rybakowski J, Owe-Larsson B, Kane JM, Johnstone EC, MacIntyre DJ, Malhotra S, González-Pinto A, Mosquera F, Babb SM, Habib pour E, Fatemi SS, Swanson C, Adler C, Young A, Hoeft F, Sivakumar K, Radoeva PD, Lallart EA, Bilker WB, Siegel SJ. PMID: 18571376.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia? Drug Discov Today. 2007 Oct; 12(19-20):870-8. Halene TB, Siegel SJ. PMID: 17933689.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    50. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology (Berl). 2007 Feb; 190(2):201-11. Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, Winey KI, Swerdlow NR, Siegel SJ. PMID: 17119931.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    51. Self-face recognition and theory of mind in patients with schizophrenia and first-degree relatives. Schizophr Res. 2006 Dec; 88(1-3):151-60. Irani F, Platek SM, Panyavin IS, Calkins ME, Kohler C, Siegel SJ, Schachter M, Gur RE, Gur RC. PMID: 16979876.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    52. Corticosterone modulates auditory gating in mouse. Neuropsychopharmacology. 2006 May; 31(5):897-903. Maxwell CR, Ehrlichman RS, Liang Y, Gettes DR, Evans DL, Kanes SJ, Abel T, Karp J, Siegel SJ. PMID: 16123740.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    53. Effects of nicotine vary across two auditory evoked potentials in the mouse. Biol Psychiatry. 2007 Jan 01; 61(1):23-30. Metzger KL, Maxwell CR, Liang Y, Siegel SJ. PMID: 16497274.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    54. The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res. 2004 Jun; 29(6):1179-88. Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, Gur RE, Turetsky BI, Siegel SJ. PMID: 15176475.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    55. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology. 2004 Apr; 29(4):739-46. Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE, Turetsky BI, Bilker WB, Lenox RH, Siegel SJ. PMID: 14735128.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    56. Symptom and demographic profiles in first-episode schizophrenia. Schizophr Res. 2004 Apr 01; 67(2-3):185-94. Gelber EI, Kohler CG, Bilker WB, Gur RC, Brensinger C, Siegel SJ, Gur RE. PMID: 14984877.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    57. Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha. Neuropsychopharmacology. 2004 Mar; 29(3):494-501. Gould TJ, Bizily SP, Tokarczyk J, Kelly MP, Siegel SJ, Kanes SJ, Abel T. PMID: 14694347; PMCID: PMC3348581.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    58. Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains. Brain Res. 2003 Nov 28; 992(1):85-95. Connolly PM, Maxwell CR, Kanes SJ, Abel T, Liang Y, Tokarczyk J, Bilker WB, Turetsky BI, Gur RE, Siegel SJ. PMID: 14604776.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    59. Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology. 2003 Apr; 28(4):675-82. Siegel SJ, Connolly P, Liang Y, Lenox RH, Gur RE, Bilker WB, Kanes SJ, Turetsky BI. PMID: 12655312.
      View in: PubMed   Mentions: 47     Fields:    Translation:Animals
    Steven's Networks
    Concepts (279)
    Derived automatically from this person's publications.
    Co-Authors (11)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department